semaglutide causes cancer GLP-1s and prevention: What’s known and what isn’t Ozempic and cancer: Does the

The ADA highlights the benefits of combining GLP-1 receptor agonists with SGLT2 inhibitors, stating: Combined use [of GLP-1 RAs and SGLT2 inhibitors] may be considered for additive cardio-kidney protection

Direct effects include increased lipolysis (fat breakdown), enhanced protein synthesis, improved glucose body function, and many body effects

**Stay hydrated.** Dehydration worsens GI side effects

If you are at the point where you want a clinician to review your options, complete the free assessment quiz to see what may be appropriate for you

Fact: Standard workplace drug tests do not screen for GLP-1 receptor agonists

Frequently Asked Questions Does everyone's blood pressure go up on compounded semaglutide